8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Oxytocin Stimulates Extracellular Ca 2+ Influx Through TRPV2 Channels in Hypothalamic Neurons to Exert Its Anxiolytic Effects

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          There is growing interest in anxiolytic and pro-social effects of the neuropeptide oxytocin (OXT), but the underlying intraneuronal mechanisms are largely unknown. Here we examined OXT-mediated anxiolysis in the hypothalamic paraventricular nucleus (PVN) of rats and effects of OXT administration on signaling events in hypothalamic primary and immortalized cells. In vivo, the application of SKF96365 prevented the anxiolytic activity of OXT in the PVN, suggesting that changes in intracellular Ca 2+ mediate the acute OXT behavioral effects. In vitro, mainly in the neurons with autonomous Ca 2+ oscillations, OXT increased intracellular Ca 2+ concentration and oscillation amplitude. Pharmacological intervention revealed OXT-dependent changes in Ca 2+ signaling that required activation of transient receptor potential vanilloid type-2 channel (TRPV2), mediated by phosphoinositide 3-kinase. TRPV2 induced the activation of the anxiolytic mitogen-activated protein kinase kinase (MEK1/2). In situ, immunohistochemistry revealed co-localization of TRPV2 and OXT in the PVN. Thus, functional and pharmacological analyses identified TRPV2 as a mediator of anxiolytic effects of OXT, conveying the OXT signal to MEK1/2 via modulation of intracellular Ca 2+.

          Related collections

          Author and article information

          Journal
          Neuropsychopharmacology
          Neuropsychopharmacology
          Neuropsychopharmacology
          Nature Publishing Group
          0893-133X
          1740-634X
          December 2015
          27 May 2015
          24 June 2015
          : 40
          : 13
          : 2938-2947
          Affiliations
          [1 ] Department of Behavioural and Molecular Neurobiology, Institute of Zoology, University of Regensburg , Regensburg, Germany
          [2 ] Department of Experimental Ophthalmology, Eye Hospital, University Medical Center Regensburg , Regensburg, Germany
          [3 ] Experimental Ophthalmology, Department of Ophthalmology, Charite University Medicine Berlin , Berlin, Germany
          Author notes
          [* ] Department of Behavioural and Molecular Neurobiology, Institute of Zoology, University of Regensburg , Universitätsstrasse 31, Regensburg 93053, Germany, Tel.: +49 941 943 3055, Fax: +49 941 943 3052, E-mail: inga.neumann@ 123456biologie.uni-regensburg.de
          [* ] Experimental Ophthalmology, Department of Ophthalmology, Charite University Medicine Berlin , Campus Virchow Clinic, Augustenburger Platz 1, Berlin 13353, Germany. Tel.: +49 30 450 654359, Fax: +49 30 450 554907, E-mail: olaf.strauss@ 123456charite.de
          [4]

          These authors are the co-first authors.

          Article
          PMC4864629 PMC4864629 4864629 npp2015147
          10.1038/npp.2015.147
          4864629
          26013963
          dde64bbd-dcba-4245-9dfb-f74f2b561da6
          Copyright © 2015 American College of Neuropsychopharmacology
          History
          : 11 September 2014
          : 02 May 2015
          : 04 May 2015
          Categories
          Original Article

          Comments

          Comment on this article